🇺🇸 Corvitol in United States

44 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Covid-19 — 5 reports (11.36%)
  2. Oedema Peripheral — 5 reports (11.36%)
  3. Pulmonary Embolism — 5 reports (11.36%)
  4. Thrombocytopenia — 5 reports (11.36%)
  5. Anaemia — 4 reports (9.09%)
  6. Full Blood Count Abnormal — 4 reports (9.09%)
  7. Malaise — 4 reports (9.09%)
  8. Neutropenia — 4 reports (9.09%)
  9. Respiratory Tract Infection — 4 reports (9.09%)
  10. Respiratory Tract Infection Bacterial — 4 reports (9.09%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Corvitol approved in United States?

Corvitol does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Corvitol in United States?

Berlin-Chemie Menarini is the originator. The local marketing authorisation holder may differ — check the official source linked above.